The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Third-party Medical Diagnosis Market Research Report 2024
Synopsis
Third-party medical testing belongs to the "Medical Diagnostic Service" sub-industry in the "Medical Service" industry. It is a service form that relies on the Independent Clinical Laboratory (ICL) to provide medical testing and diagnostic outsourcing for various medical institutions. It belongs to the branch of the third-party testing industry in the medical field. Medical diagnosis, third-party medical diagnosis, and independent medical laboratory belong to the affiliation relationship.
The global Third-party Medical Diagnosis market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.
This report aims to provide a comprehensive presentation of the global market for Third-party Medical Diagnosis, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Third-party Medical Diagnosis.
Report Scope
The Third-party Medical Diagnosis market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Third-party Medical Diagnosis market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Third-party Medical Diagnosis companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Kingmed Diagnostics Group
Dian Diagnostics Group
ADICON
Daan Gene
Hybribio Biotech
Kangmei Biotechnology
BGI Genomics Co.,Ltd
NovogeneCo.,Ltd.
Segment by Type
Hematology Testing
Genetic Disease and Rare Disease Detection
Infectious Disease Detection
Tumor Detection
Neurological Testing and Gynecological Related Testing
Segment by Application
Hospital
Community Health Services
Medical center
Desease control Centre
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Third-party Medical Diagnosis companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Third-party medical testing belongs to the "Medical Diagnostic Service" sub-industry in the "Medical Service" industry. It is a service form that relies on the Independent Clinical Laboratory (ICL) to provide medical testing and diagnostic outsourcing for various medical institutions. It belongs to the branch of the third-party testing industry in the medical field. Medical diagnosis, third-party medical diagnosis, and independent medical laboratory belong to the affiliation relationship.
The global Third-party Medical Diagnosis market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.
This report aims to provide a comprehensive presentation of the global market for Third-party Medical Diagnosis, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Third-party Medical Diagnosis.
Report Scope
The Third-party Medical Diagnosis market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Third-party Medical Diagnosis market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Third-party Medical Diagnosis companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Kingmed Diagnostics Group
Dian Diagnostics Group
ADICON
Daan Gene
Hybribio Biotech
Kangmei Biotechnology
BGI Genomics Co.,Ltd
NovogeneCo.,Ltd.
Segment by Type
Hematology Testing
Genetic Disease and Rare Disease Detection
Infectious Disease Detection
Tumor Detection
Neurological Testing and Gynecological Related Testing
Segment by Application
Hospital
Community Health Services
Medical center
Desease control Centre
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Third-party Medical Diagnosis companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Third-party Medical Diagnosis Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Hematology Testing
1.2.3 Genetic Disease and Rare Disease Detection
1.2.4 Infectious Disease Detection
1.2.5 Tumor Detection
1.2.6 Neurological Testing and Gynecological Related Testing
1.3 Market by Application
1.3.1 Global Third-party Medical Diagnosis Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Hospital
1.3.3 Community Health Services
1.3.4 Medical center
1.3.5 Desease control Centre
1.3.6 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Third-party Medical Diagnosis Market Perspective (2019-2030)
2.2 Third-party Medical Diagnosis Growth Trends by Region
2.2.1 Global Third-party Medical Diagnosis Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Third-party Medical Diagnosis Historic Market Size by Region (2019-2024)
2.2.3 Third-party Medical Diagnosis Forecasted Market Size by Region (2025-2030)
2.3 Third-party Medical Diagnosis Market Dynamics
2.3.1 Third-party Medical Diagnosis Industry Trends
2.3.2 Third-party Medical Diagnosis Market Drivers
2.3.3 Third-party Medical Diagnosis Market Challenges
2.3.4 Third-party Medical Diagnosis Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Third-party Medical Diagnosis Players by Revenue
3.1.1 Global Top Third-party Medical Diagnosis Players by Revenue (2019-2024)
3.1.2 Global Third-party Medical Diagnosis Revenue Market Share by Players (2019-2024)
3.2 Global Third-party Medical Diagnosis Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Third-party Medical Diagnosis Revenue
3.4 Global Third-party Medical Diagnosis Market Concentration Ratio
3.4.1 Global Third-party Medical Diagnosis Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Third-party Medical Diagnosis Revenue in 2023
3.5 Third-party Medical Diagnosis Key Players Head office and Area Served
3.6 Key Players Third-party Medical Diagnosis Product Solution and Service
3.7 Date of Enter into Third-party Medical Diagnosis Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Third-party Medical Diagnosis Breakdown Data by Type
4.1 Global Third-party Medical Diagnosis Historic Market Size by Type (2019-2024)
4.2 Global Third-party Medical Diagnosis Forecasted Market Size by Type (2025-2030)
5 Third-party Medical Diagnosis Breakdown Data by Application
5.1 Global Third-party Medical Diagnosis Historic Market Size by Application (2019-2024)
5.2 Global Third-party Medical Diagnosis Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Third-party Medical Diagnosis Market Size (2019-2030)
6.2 North America Third-party Medical Diagnosis Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Third-party Medical Diagnosis Market Size by Country (2019-2024)
6.4 North America Third-party Medical Diagnosis Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Third-party Medical Diagnosis Market Size (2019-2030)
7.2 Europe Third-party Medical Diagnosis Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Third-party Medical Diagnosis Market Size by Country (2019-2024)
7.4 Europe Third-party Medical Diagnosis Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Third-party Medical Diagnosis Market Size (2019-2030)
8.2 Asia-Pacific Third-party Medical Diagnosis Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Third-party Medical Diagnosis Market Size by Region (2019-2024)
8.4 Asia-Pacific Third-party Medical Diagnosis Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Third-party Medical Diagnosis Market Size (2019-2030)
9.2 Latin America Third-party Medical Diagnosis Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Third-party Medical Diagnosis Market Size by Country (2019-2024)
9.4 Latin America Third-party Medical Diagnosis Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Third-party Medical Diagnosis Market Size (2019-2030)
10.2 Middle East & Africa Third-party Medical Diagnosis Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Third-party Medical Diagnosis Market Size by Country (2019-2024)
10.4 Middle East & Africa Third-party Medical Diagnosis Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Kingmed Diagnostics Group
11.1.1 Kingmed Diagnostics Group Company Detail
11.1.2 Kingmed Diagnostics Group Business Overview
11.1.3 Kingmed Diagnostics Group Third-party Medical Diagnosis Introduction
11.1.4 Kingmed Diagnostics Group Revenue in Third-party Medical Diagnosis Business (2019-2024)
11.1.5 Kingmed Diagnostics Group Recent Development
11.2 Dian Diagnostics Group
11.2.1 Dian Diagnostics Group Company Detail
11.2.2 Dian Diagnostics Group Business Overview
11.2.3 Dian Diagnostics Group Third-party Medical Diagnosis Introduction
11.2.4 Dian Diagnostics Group Revenue in Third-party Medical Diagnosis Business (2019-2024)
11.2.5 Dian Diagnostics Group Recent Development
11.3 ADICON
11.3.1 ADICON Company Detail
11.3.2 ADICON Business Overview
11.3.3 ADICON Third-party Medical Diagnosis Introduction
11.3.4 ADICON Revenue in Third-party Medical Diagnosis Business (2019-2024)
11.3.5 ADICON Recent Development
11.4 Daan Gene
11.4.1 Daan Gene Company Detail
11.4.2 Daan Gene Business Overview
11.4.3 Daan Gene Third-party Medical Diagnosis Introduction
11.4.4 Daan Gene Revenue in Third-party Medical Diagnosis Business (2019-2024)
11.4.5 Daan Gene Recent Development
11.5 Hybribio Biotech
11.5.1 Hybribio Biotech Company Detail
11.5.2 Hybribio Biotech Business Overview
11.5.3 Hybribio Biotech Third-party Medical Diagnosis Introduction
11.5.4 Hybribio Biotech Revenue in Third-party Medical Diagnosis Business (2019-2024)
11.5.5 Hybribio Biotech Recent Development
11.6 Kangmei Biotechnology
11.6.1 Kangmei Biotechnology Company Detail
11.6.2 Kangmei Biotechnology Business Overview
11.6.3 Kangmei Biotechnology Third-party Medical Diagnosis Introduction
11.6.4 Kangmei Biotechnology Revenue in Third-party Medical Diagnosis Business (2019-2024)
11.6.5 Kangmei Biotechnology Recent Development
11.7 BGI Genomics Co.,Ltd
11.7.1 BGI Genomics Co.,Ltd Company Detail
11.7.2 BGI Genomics Co.,Ltd Business Overview
11.7.3 BGI Genomics Co.,Ltd Third-party Medical Diagnosis Introduction
11.7.4 BGI Genomics Co.,Ltd Revenue in Third-party Medical Diagnosis Business (2019-2024)
11.7.5 BGI Genomics Co.,Ltd Recent Development
11.8 NovogeneCo.,Ltd.
11.8.1 NovogeneCo.,Ltd. Company Detail
11.8.2 NovogeneCo.,Ltd. Business Overview
11.8.3 NovogeneCo.,Ltd. Third-party Medical Diagnosis Introduction
11.8.4 NovogeneCo.,Ltd. Revenue in Third-party Medical Diagnosis Business (2019-2024)
11.8.5 NovogeneCo.,Ltd. Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of TablesList of Tables
Table 1. Global Third-party Medical Diagnosis Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of Hematology Testing
Table 3. Key Players of Genetic Disease and Rare Disease Detection
Table 4. Key Players of Infectious Disease Detection
Table 5. Key Players of Tumor Detection
Table 6. Key Players of Neurological Testing and Gynecological Related Testing
Table 7. Global Third-party Medical Diagnosis Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 8. Global Third-party Medical Diagnosis Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 9. Global Third-party Medical Diagnosis Market Size by Region (2019-2024) & (US$ Million)
Table 10. Global Third-party Medical Diagnosis Market Share by Region (2019-2024)
Table 11. Global Third-party Medical Diagnosis Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 12. Global Third-party Medical Diagnosis Market Share by Region (2025-2030)
Table 13. Third-party Medical Diagnosis Market Trends
Table 14. Third-party Medical Diagnosis Market Drivers
Table 15. Third-party Medical Diagnosis Market Challenges
Table 16. Third-party Medical Diagnosis Market Restraints
Table 17. Global Third-party Medical Diagnosis Revenue by Players (2019-2024) & (US$ Million)
Table 18. Global Third-party Medical Diagnosis Market Share by Players (2019-2024)
Table 19. Global Top Third-party Medical Diagnosis Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Third-party Medical Diagnosis as of 2023)
Table 20. Ranking of Global Top Third-party Medical Diagnosis Companies by Revenue (US$ Million) in 2023
Table 21. Global 5 Largest Players Market Share by Third-party Medical Diagnosis Revenue (CR5 and HHI) & (2019-2024)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players Third-party Medical Diagnosis Product Solution and Service
Table 24. Date of Enter into Third-party Medical Diagnosis Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Third-party Medical Diagnosis Market Size by Type (2019-2024) & (US$ Million)
Table 27. Global Third-party Medical Diagnosis Revenue Market Share by Type (2019-2024)
Table 28. Global Third-party Medical Diagnosis Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 29. Global Third-party Medical Diagnosis Revenue Market Share by Type (2025-2030)
Table 30. Global Third-party Medical Diagnosis Market Size by Application (2019-2024) & (US$ Million)
Table 31. Global Third-party Medical Diagnosis Revenue Market Share by Application (2019-2024)
Table 32. Global Third-party Medical Diagnosis Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 33. Global Third-party Medical Diagnosis Revenue Market Share by Application (2025-2030)
Table 34. North America Third-party Medical Diagnosis Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 35. North America Third-party Medical Diagnosis Market Size by Country (2019-2024) & (US$ Million)
Table 36. North America Third-party Medical Diagnosis Market Size by Country (2025-2030) & (US$ Million)
Table 37. Europe Third-party Medical Diagnosis Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 38. Europe Third-party Medical Diagnosis Market Size by Country (2019-2024) & (US$ Million)
Table 39. Europe Third-party Medical Diagnosis Market Size by Country (2025-2030) & (US$ Million)
Table 40. Asia-Pacific Third-party Medical Diagnosis Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
Table 41. Asia-Pacific Third-party Medical Diagnosis Market Size by Region (2019-2024) & (US$ Million)
Table 42. Asia-Pacific Third-party Medical Diagnosis Market Size by Region (2025-2030) & (US$ Million)
Table 43. Latin America Third-party Medical Diagnosis Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 44. Latin America Third-party Medical Diagnosis Market Size by Country (2019-2024) & (US$ Million)
Table 45. Latin America Third-party Medical Diagnosis Market Size by Country (2025-2030) & (US$ Million)
Table 46. Middle East & Africa Third-party Medical Diagnosis Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 47. Middle East & Africa Third-party Medical Diagnosis Market Size by Country (2019-2024) & (US$ Million)
Table 48. Middle East & Africa Third-party Medical Diagnosis Market Size by Country (2025-2030) & (US$ Million)
Table 49. Kingmed Diagnostics Group Company Detail
Table 50. Kingmed Diagnostics Group Business Overview
Table 51. Kingmed Diagnostics Group Third-party Medical Diagnosis Product
Table 52. Kingmed Diagnostics Group Revenue in Third-party Medical Diagnosis Business (2019-2024) & (US$ Million)
Table 53. Kingmed Diagnostics Group Recent Development
Table 54. Dian Diagnostics Group Company Detail
Table 55. Dian Diagnostics Group Business Overview
Table 56. Dian Diagnostics Group Third-party Medical Diagnosis Product
Table 57. Dian Diagnostics Group Revenue in Third-party Medical Diagnosis Business (2019-2024) & (US$ Million)
Table 58. Dian Diagnostics Group Recent Development
Table 59. ADICON Company Detail
Table 60. ADICON Business Overview
Table 61. ADICON Third-party Medical Diagnosis Product
Table 62. ADICON Revenue in Third-party Medical Diagnosis Business (2019-2024) & (US$ Million)
Table 63. ADICON Recent Development
Table 64. Daan Gene Company Detail
Table 65. Daan Gene Business Overview
Table 66. Daan Gene Third-party Medical Diagnosis Product
Table 67. Daan Gene Revenue in Third-party Medical Diagnosis Business (2019-2024) & (US$ Million)
Table 68. Daan Gene Recent Development
Table 69. Hybribio Biotech Company Detail
Table 70. Hybribio Biotech Business Overview
Table 71. Hybribio Biotech Third-party Medical Diagnosis Product
Table 72. Hybribio Biotech Revenue in Third-party Medical Diagnosis Business (2019-2024) & (US$ Million)
Table 73. Hybribio Biotech Recent Development
Table 74. Kangmei Biotechnology Company Detail
Table 75. Kangmei Biotechnology Business Overview
Table 76. Kangmei Biotechnology Third-party Medical Diagnosis Product
Table 77. Kangmei Biotechnology Revenue in Third-party Medical Diagnosis Business (2019-2024) & (US$ Million)
Table 78. Kangmei Biotechnology Recent Development
Table 79. BGI Genomics Co.,Ltd Company Detail
Table 80. BGI Genomics Co.,Ltd Business Overview
Table 81. BGI Genomics Co.,Ltd Third-party Medical Diagnosis Product
Table 82. BGI Genomics Co.,Ltd Revenue in Third-party Medical Diagnosis Business (2019-2024) & (US$ Million)
Table 83. BGI Genomics Co.,Ltd Recent Development
Table 84. NovogeneCo.,Ltd. Company Detail
Table 85. NovogeneCo.,Ltd. Business Overview
Table 86. NovogeneCo.,Ltd. Third-party Medical Diagnosis Product
Table 87. NovogeneCo.,Ltd. Revenue in Third-party Medical Diagnosis Business (2019-2024) & (US$ Million)
Table 88. NovogeneCo.,Ltd. Recent Development
Table 89. Research Programs/Design for This Report
Table 90. Key Data Information from Secondary Sources
Table 91. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Third-party Medical Diagnosis Market Size Comparison by Type (2024-2030) & (US$ Million)
Figure 2. Global Third-party Medical Diagnosis Market Share by Type: 2023 VS 2030
Figure 3. Hematology Testing Features
Figure 4. Genetic Disease and Rare Disease Detection Features
Figure 5. Infectious Disease Detection Features
Figure 6. Tumor Detection Features
Figure 7. Neurological Testing and Gynecological Related Testing Features
Figure 8. Global Third-party Medical Diagnosis Market Size Comparison by Application (2024-2030) & (US$ Million)
Figure 9. Global Third-party Medical Diagnosis Market Share by Application: 2023 VS 2030
Figure 10. Hospital Case Studies
Figure 11. Community Health Services Case Studies
Figure 12. Medical center Case Studies
Figure 13. Desease control Centre Case Studies
Figure 14. Others Case Studies
Figure 15. Third-party Medical Diagnosis Report Years Considered
Figure 16. Global Third-party Medical Diagnosis Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 17. Global Third-party Medical Diagnosis Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 18. Global Third-party Medical Diagnosis Market Share by Region: 2023 VS 2030
Figure 19. Global Third-party Medical Diagnosis Market Share by Players in 2023
Figure 20. Global Top Third-party Medical Diagnosis Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Third-party Medical Diagnosis as of 2023)
Figure 21. The Top 10 and 5 Players Market Share by Third-party Medical Diagnosis Revenue in 2023
Figure 22. North America Third-party Medical Diagnosis Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 23. North America Third-party Medical Diagnosis Market Share by Country (2019-2030)
Figure 24. United States Third-party Medical Diagnosis Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 25. Canada Third-party Medical Diagnosis Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 26. Europe Third-party Medical Diagnosis Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 27. Europe Third-party Medical Diagnosis Market Share by Country (2019-2030)
Figure 28. Germany Third-party Medical Diagnosis Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. France Third-party Medical Diagnosis Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 30. U.K. Third-party Medical Diagnosis Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 31. Italy Third-party Medical Diagnosis Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 32. Russia Third-party Medical Diagnosis Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 33. Nordic Countries Third-party Medical Diagnosis Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 34. Asia-Pacific Third-party Medical Diagnosis Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 35. Asia-Pacific Third-party Medical Diagnosis Market Share by Region (2019-2030)
Figure 36. China Third-party Medical Diagnosis Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 37. Japan Third-party Medical Diagnosis Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 38. South Korea Third-party Medical Diagnosis Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 39. Southeast Asia Third-party Medical Diagnosis Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 40. India Third-party Medical Diagnosis Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 41. Australia Third-party Medical Diagnosis Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 42. Latin America Third-party Medical Diagnosis Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 43. Latin America Third-party Medical Diagnosis Market Share by Country (2019-2030)
Figure 44. Mexico Third-party Medical Diagnosis Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 45. Brazil Third-party Medical Diagnosis Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 46. Middle East & Africa Third-party Medical Diagnosis Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 47. Middle East & Africa Third-party Medical Diagnosis Market Share by Country (2019-2030)
Figure 48. Turkey Third-party Medical Diagnosis Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 49. Saudi Arabia Third-party Medical Diagnosis Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 50. Kingmed Diagnostics Group Revenue Growth Rate in Third-party Medical Diagnosis Business (2019-2024)
Figure 51. Dian Diagnostics Group Revenue Growth Rate in Third-party Medical Diagnosis Business (2019-2024)
Figure 52. ADICON Revenue Growth Rate in Third-party Medical Diagnosis Business (2019-2024)
Figure 53. Daan Gene Revenue Growth Rate in Third-party Medical Diagnosis Business (2019-2024)
Figure 54. Hybribio Biotech Revenue Growth Rate in Third-party Medical Diagnosis Business (2019-2024)
Figure 55. Kangmei Biotechnology Revenue Growth Rate in Third-party Medical Diagnosis Business (2019-2024)
Figure 56. BGI Genomics Co.,Ltd Revenue Growth Rate in Third-party Medical Diagnosis Business (2019-2024)
Figure 57. NovogeneCo.,Ltd. Revenue Growth Rate in Third-party Medical Diagnosis Business (2019-2024)
Figure 58. Bottom-up and Top-down Approaches for This Report
Figure 59. Data Triangulation
Figure 60. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
